A preoperative radiogenomic model based on quantitative heterogeneity for predicting outcomes in triple-negative breast cancer patients who underwent neoadjuvant chemotherapy.
Jiayin ZhouYansong BaiYing ZhangZezhou WangShiyun SunLuyi LinYajia GuChao YouPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2024)
Multiscale heterogeneity characterized by DCE-MRI could effectively predict the pCR and prognosis of TNBC patients. The radiogenomic model could serve as a valuable biomarker to improve the prediction performance.
Keyphrases
- neoadjuvant chemotherapy
- end stage renal disease
- single cell
- contrast enhanced
- locally advanced
- chronic kidney disease
- newly diagnosed
- lymph node
- ejection fraction
- magnetic resonance imaging
- patients undergoing
- prognostic factors
- sentinel lymph node
- peritoneal dialysis
- high resolution
- type diabetes
- squamous cell carcinoma
- computed tomography
- patient reported outcomes
- magnetic resonance
- skeletal muscle
- patient reported
- glycemic control